OpenAlex
PricingAboutJobs
Log inGet started
Work

Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice

HTML

Year: 2017
Type: article
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-17-0606
Authors: Elizabeth Ahern, Heidi Harjunpää, Deborah Barkauskas, Stacey Allen, Kazuyoshi Takeda, Hideo Yagita, David Wyld, William C. Dougall, Michele W.L. Teng, Mark J. Smyth
Institutions: The University of Queensland, QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Juntendo University
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: RANKL blockade, CTLA-4 blockade, combination immunotherapy, antitumor immunity, regulatory T cells, tumor-infiltrating lymphocytes, Fc receptors, natural killer cells, CD8+ T cells, tumor-associated macrophages, myeloid-derived suppressor cells, dendritic cells, RANK, experimental metastasis, tumor growth, immune checkpoint inhibitors
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2701487182
FWCI: 4.685
Cites: 56
Cited by: 91
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security